| Nome |
# |
|
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV, file e31e124e-8059-987f-e053-3705fe0a095a
|
542
|
|
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature, file e31e124d-5505-987f-e053-3705fe0a095a
|
538
|
|
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report, file e31e124d-85d9-987f-e053-3705fe0a095a
|
475
|
|
Age of HIV Acquisition Affects the Risk of Multi-Morbidity after 25 Years of Infection Exposure, file e31e124d-af98-987f-e053-3705fe0a095a
|
379
|
|
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study, file e31e124d-6925-987f-e053-3705fe0a095a
|
375
|
|
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach, file e31e124d-d7a6-987f-e053-3705fe0a095a
|
325
|
|
Rituximab in people living with HIV affected by immune-mediated renal diseases: a case-series, file e31e124e-c9e0-987f-e053-3705fe0a095a
|
319
|
|
Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments, file e31e124e-edb1-987f-e053-3705fe0a095a
|
317
|
|
Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient, file e31e124e-4655-987f-e053-3705fe0a095a
|
305
|
|
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study, file e31e124c-de9d-987f-e053-3705fe0a095a
|
286
|
|
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study, file e31e124e-7943-987f-e053-3705fe0a095a
|
263
|
|
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation, file e31e124c-cf19-987f-e053-3705fe0a095a
|
258
|
|
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays, file e31e124b-bcd0-987f-e053-3705fe0a095a
|
244
|
|
Migration and health: A retrospective study about the prevalence of HBV, HIV, HCV, tuberculosis and syphilis infections amongst newly arrived migrants screened at the Infectious Diseases Unit of Modena, Italy, file e31e124d-e810-987f-e053-3705fe0a095a
|
228
|
|
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity, file e31e124c-8e73-987f-e053-3705fe0a095a
|
217
|
|
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome, file e31e124f-5fd0-987f-e053-3705fe0a095a
|
208
|
|
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians, file e31e124d-31a8-987f-e053-3705fe0a095a
|
204
|
|
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia., file e31e124e-49f4-987f-e053-3705fe0a095a
|
203
|
|
Reliable and Accurate CD4+ T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and “CD4 Easy Count Kit-Dry”, as Revealed by the Comparison with the Gold Standard Dual Platform Technology, file e31e124a-fe2e-987f-e053-3705fe0a095a
|
200
|
|
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients, file e31e124d-39c7-987f-e053-3705fe0a095a
|
195
|
|
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial, file e31e1250-a172-987f-e053-3705fe0a095a
|
194
|
|
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator., file e31e124e-dc91-987f-e053-3705fe0a095a
|
192
|
|
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion, file e31e124e-b86f-987f-e053-3705fe0a095a
|
189
|
|
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study, file e31e124f-481b-987f-e053-3705fe0a095a
|
188
|
|
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy, file e31e124d-91a9-987f-e053-3705fe0a095a
|
186
|
|
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study., file e31e124f-ae0a-987f-e053-3705fe0a095a
|
182
|
|
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease, file e31e124c-8387-987f-e053-3705fe0a095a
|
171
|
|
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus, file e31e124d-a658-987f-e053-3705fe0a095a
|
167
|
|
Changing Incidence and Risk Factors for Kaposi Sarcoma by Time since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies, file e31e124e-f2fc-987f-e053-3705fe0a095a
|
167
|
|
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis, file 6f9d0db0-bda2-45bd-ad55-a3bbe189634c
|
163
|
|
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study, file e31e124d-31af-987f-e053-3705fe0a095a
|
163
|
|
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients, file e31e124f-ad19-987f-e053-3705fe0a095a
|
161
|
|
Machine learning algorithm to predict weight change in ART experienced PWH, file 6fc0ae94-f3c1-4586-831c-fa95786eeb6f
|
160
|
|
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients, file e31e124c-dcf7-987f-e053-3705fe0a095a
|
160
|
|
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART, file e31e124d-af9a-987f-e053-3705fe0a095a
|
160
|
|
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV, file e31e124d-8783-987f-e053-3705fe0a095a
|
159
|
|
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study, file e31e124d-911b-987f-e053-3705fe0a095a
|
158
|
|
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies., file e31e124f-e594-987f-e053-3705fe0a095a
|
156
|
|
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE), file e31e124e-2b37-987f-e053-3705fe0a095a
|
153
|
|
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey, file e31e124c-33a2-987f-e053-3705fe0a095a
|
148
|
|
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles, file e31e124c-3339-987f-e053-3705fe0a095a
|
147
|
|
Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015, file e31e124d-857a-987f-e053-3705fe0a095a
|
146
|
|
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14, file e31e124e-b21e-987f-e053-3705fe0a095a
|
146
|
|
Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy, file e31e124b-d7a7-987f-e053-3705fe0a095a
|
145
|
|
The Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study, file e31e124d-bf38-987f-e053-3705fe0a095a
|
145
|
|
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study, file e31e124f-b7bb-987f-e053-3705fe0a095a
|
145
|
|
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study., file e31e124f-c99d-987f-e053-3705fe0a095a
|
145
|
|
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study., file e31e124a-a8fe-987f-e053-3705fe0a095a
|
144
|
|
Compression of frailty in adults living with HIV, file e31e124d-c881-987f-e053-3705fe0a095a
|
144
|
|
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population, file e31e124e-88af-987f-e053-3705fe0a095a
|
143
|
|
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC, file e31e124d-aff0-987f-e053-3705fe0a095a
|
142
|
|
Predictors of transitions in frailty severity and mortality among people aging with HIV, file e31e124d-01ec-987f-e053-3705fe0a095a
|
139
|
|
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol, file e31e124e-4995-987f-e053-3705fe0a095a
|
137
|
|
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people, file e31e124e-afdd-987f-e053-3705fe0a095a
|
137
|
|
Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial, file e31e124e-ff8b-987f-e053-3705fe0a095a
|
137
|
|
The Lisbon patient: Exceptional longevity with HIV suggests healthy aging as an ultimate goal for HIV care, file e31e124e-443d-987f-e053-3705fe0a095a
|
136
|
|
Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence, file e31e124d-8576-987f-e053-3705fe0a095a
|
135
|
|
Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons, file e31e124d-8571-987f-e053-3705fe0a095a
|
134
|
|
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients, file e31e124d-361f-987f-e053-3705fe0a095a
|
132
|
|
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae, file e31e124e-c723-987f-e053-3705fe0a095a
|
130
|
|
Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease, file e31e124e-b703-987f-e053-3705fe0a095a
|
129
|
|
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program, file e31e124e-4eba-987f-e053-3705fe0a095a
|
128
|
|
Peritoneal dialysis in the time of coronavirus disease 2019, file e31e124e-53d7-987f-e053-3705fe0a095a
|
128
|
|
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e31e124d-d06f-987f-e053-3705fe0a095a
|
126
|
|
Benefits and medium-term outcome of the Sorin Pericarbon Freedom stentless aortic prosthesis in cases of acute bacterial endocarditis, file e31e124e-f5bd-987f-e053-3705fe0a095a
|
126
|
|
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection., file e31e124d-ea5d-987f-e053-3705fe0a095a
|
125
|
|
Tocilizumab in patients with severe COVID-19: a retrospective cohort study, file e31e124e-979d-987f-e053-3705fe0a095a
|
125
|
|
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART., file e31e124a-aea8-987f-e053-3705fe0a095a
|
124
|
|
Common genetic variation and the control of HIV-1 in humans., file e31e124a-ade6-987f-e053-3705fe0a095a
|
121
|
|
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial, file e31e124e-d215-987f-e053-3705fe0a095a
|
121
|
|
Mucorales-specific T cells in patients with hematologic malignancies, file e31e124b-b2de-987f-e053-3705fe0a095a
|
120
|
|
Endobronchial valve positioning for alveolar-pleural fistula following ICU management of severe COVID-19 pneumonia., file e31e124f-b69f-987f-e053-3705fe0a095a
|
120
|
|
Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis., file e31e124a-adb1-987f-e053-3705fe0a095a
|
119
|
|
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study, file e31e124e-6c7f-987f-e053-3705fe0a095a
|
118
|
|
Comparison of Kaposi Sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: A multiregional multicohort study, file e31e124e-b60a-987f-e053-3705fe0a095a
|
118
|
|
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies., file e31e124a-aead-987f-e053-3705fe0a095a
|
116
|
|
Mitochondrial DNA: a proinflammatory 'enemy from within' during HIV infection?, file e31e124e-08fa-987f-e053-3705fe0a095a
|
116
|
|
Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE, file e31e124e-4eb8-987f-e053-3705fe0a095a
|
115
|
|
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy., file e31e124e-03ff-987f-e053-3705fe0a095a
|
113
|
|
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects., file e31e124a-a901-987f-e053-3705fe0a095a
|
107
|
|
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales, file e31e124e-2a78-987f-e053-3705fe0a095a
|
107
|
|
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI., file e31e124a-a8ff-987f-e053-3705fe0a095a
|
106
|
|
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study), file e31e124e-7351-987f-e053-3705fe0a095a
|
106
|
|
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia, file f31b89d5-71b0-42a5-8e26-118c1e723364
|
106
|
|
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency., file e31e124e-fe69-987f-e053-3705fe0a095a
|
104
|
|
Impact of polypharmacy on antiretroviral prescription in people living with HIV., file e31e124f-59de-987f-e053-3705fe0a095a
|
104
|
|
Thymus Imaging Detection and Size Is Inversely Associated With Metabolic Syndrome and Frailty in People With HIV, file e31e124e-a1a1-987f-e053-3705fe0a095a
|
103
|
|
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study, file e31e124e-d5f1-987f-e053-3705fe0a095a
|
102
|
|
Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio, file e31e124b-cb40-987f-e053-3705fe0a095a
|
100
|
|
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe, file e31e124e-ad52-987f-e053-3705fe0a095a
|
99
|
|
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART, file e31e124f-14ca-987f-e053-3705fe0a095a
|
99
|
|
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period, file e31e124e-6b15-987f-e053-3705fe0a095a
|
98
|
|
Kaposi sarcoma risk in HIV-infected children and adolescents on combination antiretroviral therapy from sub-Saharan Africa, Europe, and Asia, file e31e124e-ad5d-987f-e053-3705fe0a095a
|
98
|
|
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study, file e31e124e-f292-987f-e053-3705fe0a095a
|
98
|
|
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection, file e31e124f-7ecc-987f-e053-3705fe0a095a
|
97
|
|
Decay pattern of anti–SARS–CoV–2 antibodies in PWH, file eedd2bb9-bea8-46e6-82d0-0611adf6625b
|
97
|
|
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus, file e31e124e-01bf-987f-e053-3705fe0a095a
|
96
|
|
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study, file e31e124e-f951-987f-e053-3705fe0a095a
|
95
|
|
A prospective randomized trial on abacavir/ lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study), file e31e124d-ccbe-987f-e053-3705fe0a095a
|
94
|
|
Breast tuberculosis: A case report of primary type mammary tuberculosis, file e31e124e-26f7-987f-e053-3705fe0a095a
|
90
|
| Totale |
16.681 |
